ACP3: Key Enzyme in Thiamine Biosynthesis and Potential Drug Target

Target Name: ACP3

NCBI ID: G55

ACP3

ACP3: Key Enzyme in Thiamine Biosynthesis and Potential Drug Target

Thiamine monophosphatase (ACP3) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the thiamine biosynthesis pathway, which is responsible for producing thiamine, a crucial coenzyme for the transfer of electrons in the cell. Thiamine is essential for the growth, development, and function of all living organisms. However, thiamine deficiency is a common disorder that can lead to a range of negative health consequences. The aim of this article is to provide an overview of ACP3, including its structure, function, and potential as a drug target or biomarker.

Structure

ACP3 is a 22 kDa protein that consists of 218 amino acid residues. It has a distinct N-terminus that contains a catalytic core and a C-terminus that is involved in its interactions with other proteins. The catalytic core of ACP3 consists of a Rossmann-fold, a conserved structural motif that is commonly found in proteins that are involved in chemical catalysis. This motif is responsible for the stability and active site stability of the enzyme.

Function

ACP3 is the catalytic enzyme of the thiamine biosynthesis pathway. Thiamine is a crucial coenzyme that is involved in the transfer of electrons in the cell. It plays a vital role in the regulation of various cellular processes, including DNA replication, cell division, and neurotransmitter synthesis. Thiamine deficiency is a common disorder that can lead to a range of negative health consequences, including the development of certain diseases.

ACP3 is involved in the production of thiamine from its precursor, thiamine-6-phosphate. Thiamine-6-phosphate is a crucial precursor for the production of thiamine, as it provides the carbon skeleton for thiamine. The thiamine biosynthesis pathway involves the transfer of electrons from the precursor to the active site of the enzyme, where it is converted to its final product, thiamine.

ACP3 is a key enzyme in this pathway, as its activity is required for the production of thiamine. The activity of ACP3 can be inhibited by various drugs, including thiamine salts, which inhibit the transfer of electrons from the precursor to the active site. This inhibition can lead to a decrease in thiamine production and a decrease in the activity of the enzyme.

Potential as a Drug Target

The potential of ACP3 as a drug target is high due to its involvement in the production of thiamine, which is a crucial coenzyme for various cellular processes. Thiamine plays a vital role in the regulation of DNA replication, cell division, and neurotransmitter synthesis, among other processes. Therefore, inhibitors of ACP3 have the potential to be useful in treating various diseases that are caused by thiamine deficiency or imbalance.

One of the potential benefits of ACP3 as a drug target is its effectiveness in treating thiamine deficiency. Thiamine deficiency is a common disorder that can lead to a range of negative health consequences, including the development of certain diseases. However, treating thiamine deficiency is a challenging task, as it requires the use of broad inhibitors that can inhibit the activity of all enzymes involved in the thiamine biosynthesis pathway.

In addition, ACP3 has been shown to be involved in various cellular processes, including cell signaling, cell adhesion, and neurotransmission. Therefore, inhibitors of ACP3 have the potential to be useful in treating a range of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Conclusion

In conclusion, ACP3 is a protein that is involved in the production of thiamine, a crucial coenzyme for the transfer of electrons in the cell. Its activity is

Protein Name: Acid Phosphatase 3

Functions: A non-specific tyrosine phosphatase that dephosphorylates a diverse number of substrates under acidic conditions (pH 4-6) including alkyl, aryl, and acyl orthophosphate monoesters and phosphorylated proteins (PubMed:10506173, PubMed:15280042, PubMed:20498373, PubMed:9584846). Has lipid phosphatase activity and inactivates lysophosphatidic acid in seminal plasma (PubMed:10506173, PubMed:15280042)

The "ACP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets